Niflumic Acid, 95%, 25g

5,6-Dihydrodibenzo[b,f]azocine, 98%, 1g

monoclonale di topo anti-cheratina di tipo II, Ks pan1-8, 0,2 ml

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-azabicyclo[4.1.0]heptane-3-carboxylate, 98%, 250mg

(3S,4R)-1-(tert-Butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid, 95%, 1g

3-(2-aminoethyl)-5,5-dimethyl-1,3-thiazolidine-2,4-dione hydrochloride, 250mg

1-(Bromomethyl)-2,3-dimethylbenzene, 95.0%, 10g

[(4-ethyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetic acid, 95.0%, 500mg

3-[3,5-dimethyl-1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-pyrazol-4-yl]propanoic acid, 95.0%, 500mg

tert-Butyl 1-picolinoylpiperidin-4-ylcarbamate, 95.0%, 1g

3-Chlorothiobenzamide, 98.0%, 25g

Benzyl (R)-2-hydroxypropanoate, 98+%, 250mg

METHYL 1H-INDAZOLE-4-CARBOXYLATE, 97%, 100g